#TRVI shares new insights from Phase 2a RIVER trial, highlighting Haduvio’s potential in treating refractory chronic cough. Promising results for patients with 10+ coughs/hour!
#TreviThera #ChronicCough #Biotech #Haduvio prismmarketview.com/trevi-therap...